Login / Signup

First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system.

Klaus-Jürgen GutlebenThomas EitzRandy WestlundJan F GummertPhilipp SommerHenrik Fox
Published in: Journal of cardiovascular electrophysiology (2020)
The remedē system is a novel fully implantable transvenous phrenic nerve stimulation (TPNS) device developed to treat central sleep apnea. No information is published on how to explant or replace its leads. An eighty-one year-old had a fractured lead and we removed it over a wire. However, unbreachable resistances occurred with a new lead deployed over the enclosed wire and interventional endovascular techniques were performed to reimplant a new fully functioning system. This first report demonstrates TPNS lead exchange is possible but can be challenging. Interventional maneuvers and techniques, including balloon angioplasty, can facilitate this procedure.
Keyphrases
  • sleep apnea
  • obstructive sleep apnea
  • randomized controlled trial
  • healthcare
  • health information
  • social media